In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation
1:09-md-02118
Overview
Parties
In Re
Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation Operating Company
Represented By
0 Attorneys ListedDefendant
Anchen Pharmaceuticals Inc. Operating Company
Represented By
0 Attorneys ListedMylan Pharmaceuticals Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Notice Only
Ivax International GMBH NPE (Individual / Inventor)
Represented By
0 Attorneys ListedCounter Claimant
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No Co-Pending Disputes Detected in Current Index
There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
(0 total)Docket documents haven't synced yet — they're refreshed once a day. Check back soon, or open the CasLoc app for the live view in the meantime.